Our data indicated that neither resistance to cisplatin nor basal migration potential (along with the site of origin) mattered in the case of STAT3 activity, the inhibition of which significantly reduced SNAIL 1 and SNAIL 2 expression, altered cadherin level and sensitized all tested ovarian cancer cell lines to cisplatin. This evidence concerns the gene CDH17 and ovarian carcinoma.